Form D · Other Health Care

Summus Global, Inc.

New York, NY · CIK 0001650331

Offering snapshot reported Apr 7, 2026 · SEC filing

Reported sold
$20M
Offering amount: $27M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 26, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 7, 2026Initial$20,000,000No comparison3SEC filing
Aug 6, 2025Initial$7,500,000No comparison1SEC filing
Aug 17, 2023Initial$19,500,000No comparison5SEC filing
Jan 28, 2022Initial$15,000,000No comparison2SEC filing
Apr 9, 2021Initial$15,999,985No comparison19SEC filing
Aug 10, 2015Initial$1,340,000No comparison21SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-579367

Source: Form D, filed Apr 7, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rick Buhrman Director
Julian Flannery Director, Executive
Scott Harrison Director
Kristi Henderson Director
Aftab Kherani Director
Arif Nathoo Director
Dennis Purcell Executive
Ayman Sabi Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
10 East 40th Street, Suite 1910
New York, NY, 10018